{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:47:27Z","timestamp":1794498447886,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG079149"],"award-info":[{"award-number":["RF1AG079149"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG058571"],"award-info":[{"award-number":["AG058571"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG073697"],"award-info":[{"award-number":["AG073697"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92021D00001"],"award-info":[{"award-number":["75N92021D00001"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92021D00002"],"award-info":[{"award-number":["75N92021D00002"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92021D00003"],"award-info":[{"award-number":["75N92021D00003"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92021D00004"],"award-info":[{"award-number":["75N92021D00004"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92021D00005"],"award-info":[{"award-number":["75N92021D00005"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Apolipoprotein E (\n                      <jats:italic>APOE<\/jats:italic>\n                      ) \u03b54 allele is the strongest genetic risk factor for late onset Alzheimer\u2019s disease (AD). This case-cohort study used targeted plasma biomarkers and large-scale proteomics to examine the biological mechanisms that allow some\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers to maintain normal cognitive functioning in older adulthood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers and\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b53 homozygotes enrolled in the Women\u2019s Health Initiative Memory Study (WHIMS) from 1996 to 1999 were classified as\n                      <jats:italic>resilient<\/jats:italic>\n                      if they remained cognitively unimpaired beyond age 80, and as\n                      <jats:italic>non-resilient<\/jats:italic>\n                      if they developed cognitive impairment before or at age 80. AD pathology (A\u00df\n                      <jats:sub>42\/40<\/jats:sub>\n                      ) and neurodegeneration (NfL, tau) biomarkers, as well as 1007 proteins (Olink) were quantified in blood collected at study enrollment (on average 14 years prior) when participants were cognitively normal. We identified plasma proteins that distinguished between resilient and non-resilient\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers, examined whether these associations generalized to\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b53 homozygotes, and replicated these findings in the UK Biobank.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1610 participants were included (baseline age: 71.3 [3.8 SD] years; all White; 42%\n                      <jats:italic>APOE\u03b5<\/jats:italic>\n                      4 carriers). Compared to resilient\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers, non-resilient\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers had lower A\u00df\n                      <jats:sub>42\/40<\/jats:sub>\n                      \/tau ratio and greater NfL at baseline. Proteomic analyses identified four proteins differentially expressed between resilient and non-resilient\n                      <jats:italic>APOE\u03b5<\/jats:italic>\n                      4 carriers at an FDR-corrected\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05. While one of the candidate proteins, a marker of neuronal injury (NfL), also distinguished resilient from non-resilient\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b53 homozygotes, the other three proteins, known to be involved in lipid metabolism (ANGPTL4) and immune signaling (PTX3, NCR1), only predicted resilient vs. non-resilient status among\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers (protein*genotype interaction-\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Three of these four proteins also predicted 14-year dementia risk among\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers in the UK Biobank validation sample (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20099420). While the candidate proteins showed little to no association with targeted biomarkers of AD pathology, protein network and enrichment analyses suggested that natural killer (NK) cell and T lymphocyte signaling (via PKC-\u03b8) distinguished resilient from non-resilient\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We identified and replicated a plasma proteomic signature associated with cognitive resilience among\n                      <jats:italic>APOE\u03b5<\/jats:italic>\n                      4 carriers. These proteins implicate specific immune processes in the preservation of cognitive status despite elevated genetic risk for AD. Future studies in diverse cohorts will be needed to assess the generalizability of these results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-024-00772-2","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T08:02:20Z","timestamp":1730361740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Proteomic analysis of APOE\u03b54 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-9853","authenticated-orcid":false,"given":"Keenan A.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Moghekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruin","family":"Moaddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke C.","family":"Pilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Espeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladdin H.","family":"Shadyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kapogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"772_CR1","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. Alzheimers Dement; 2023;19:1598\u2013695.","DOI":"10.1002\/alz.13016"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.12362","volume":"17","author":"KB Rajan","year":"2021","unstructured":"Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020\u20132060). Alzheimer\u2019s Dement Alzheimers Dement. 2021;17:1966\u201375.","journal-title":"Alzheimer\u2019s Dement Alzheimers Dement"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"E Corder","year":"1993","unstructured":"Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Sci (80-). 1993;261:921\u20133.","journal-title":"Sci (80-)"},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet Nat Genet. 2007;39:17\u201323.","journal-title":"Nat Genet Nat Genet"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet Nat Genet. 1994;7:180\u20134.","journal-title":"Nat Genet Nat Genet"},{"key":"772_CR6","doi-asserted-by":"crossref","unstructured":"Roses AD, Saunders AM, Corder EH, Pericak-Vance MA, Han SH, Einstein G, et al. Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer\u2019s disease. Arzneimittelforschung. Arzneimittelforschung; 1995. pp. 413\u20137.","DOI":"10.1016\/0022-510X(94)90109-0"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","volume":"68","author":"AS Fleisher","year":"2011","unstructured":"Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, et al. Using positron emission tomography and florbetapir F 18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol Arch Neurol. 2011;68:1404\u201311.","journal-title":"Arch Neurol Arch Neurol"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.neurobiolaging.2015.04.001","volume":"36","author":"SM Resnick","year":"2015","unstructured":"Resnick SM, Bilgel M, Moghekar A, An Y, Cai Q, Wang MC, et al. Changes in A\u03b2 biomarkers and associations with APOE genotype in 2 longitudinal cohorts. Neurobiol Aging. 2015;36:2333\u20139.","journal-title":"Neurobiol Aging"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jalz.2015.08.166","volume":"12","author":"M Bilgel","year":"2016","unstructured":"Bilgel M, An Y, Zhou Y, Wong DF, Prince JL, Ferrucci L, et al. Individual estimates of age at detectable amyloid onset for risk factor assessment. Alzheimer\u2019s Dement Alzheimers Dement. 2016;12:373\u20139.","journal-title":"Alzheimer\u2019s Dement Alzheimers Dement"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","volume":"13","author":"CR Jack","year":"2014","unstructured":"Jack CR, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, et al. Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50\u201389 years: a cross-sectional study. Lancet Neurol Lancet Neurol. 2014;13:997\u20131005.","journal-title":"Lancet Neurol Lancet Neurol"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s Disease. N Engl J Med N Engl J Med. 2012;367:795\u2013804.","journal-title":"N Engl J Med N Engl J Med"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy ME, Andrews SJ, Le Guen Y, Cuccaro M, Farrer LA, Napolioni V, et al. APOE genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry. JAMA Neurol JAMA Neurol. 2023;80:1284\u201394.","journal-title":"JAMA Neurol JAMA Neurol"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/gps.5199","volume":"34","author":"KM Hayden","year":"2019","unstructured":"Hayden KM, Gaussoin SA, Hunter JC, Manson JAE, Sachs BC, Shadyab AH, et al. Cognitive resilience among APOE \u03b54 carriers in the oldest old. Int J Geriatr Psychiatry Int J Geriatr Psychiatry. 2019;34:1833\u201344.","journal-title":"Int J Geriatr Psychiatry Int J Geriatr Psychiatry"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamaneurol.2014.3978","volume":"72","author":"AR Kaup","year":"2015","unstructured":"Kaup AR, Nettiksimmons J, Harris TB, Sink KM, Satterfield S, Metti AL, et al. Cognitive resilience to apolipoprotein E \u03b54: contributing factors in black and white older adults. JAMA Neurol JAMA Neurol. 2015;72:340\u20138.","journal-title":"JAMA Neurol JAMA Neurol"},{"key":"772_CR15","first-page":"937","volume":"72","author":"KL McDermott","year":"2017","unstructured":"McDermott KL, McFall GP, Andrews SJ, Anstey KJ, Dixon RA. Memory resilience to Alzheimer\u2019s genetic risk: Sex effects in Predictor profiles. Journals gerontol - ser B Psychol Sci Soc Sci. J Gerontol B Psychol Sci Soc Sci. 2017;72:937\u201346.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","volume":"291","author":"SA Shumaker","year":"2004","unstructured":"Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women\u2019s Health Initiative Memory Study. JAMA JAMA. 2004;291:2947\u201358.","journal-title":"JAMA JAMA"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M. Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: the women\u2019s Health Initiative Randomized Controlled Trial. J Am Med Assoc JAMA. 2004;291:1701\u201312.","journal-title":"J Am Med Assoc JAMA"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","volume":"291","author":"MA Espeland","year":"2004","unstructured":"Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JAE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive funtion in postmenopausal women: women\u2019s Health Initiative Memory Study. JAMA JAMA. 2004;291:2959\u201368.","journal-title":"JAMA JAMA"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jalz.2017.04.004","volume":"13","author":"KM Hayden","year":"2017","unstructured":"Hayden KM, Beavers DP, Steck SE, Hebert JR, Tabung FK, Shivappa N, et al. The association between an inflammatory diet and global cognitive function and incident dementia in older women: the women\u2019s Health Initiative Memory Study. Alzheimer\u2019s Dement Alzheimers Dement. 2017;13:1187\u201396.","journal-title":"Alzheimer\u2019s Dement Alzheimers Dement"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.2354","volume":"44","author":"B Howie","year":"2012","unstructured":"Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet Nat Genet. 2012;44:955\u20139.","journal-title":"Nat Genet Nat Genet"},{"key":"772_CR21","doi-asserted-by":"crossref","unstructured":"Qin W, Li W, Wang Q, Gong M, Li T, Shi Y et al. Race-Related Association between APOE Genotype and Alzheimer\u2019s Disease: a systematic review and Meta-analysis. J. Alzheimer\u2019s Dis. J Alzheimers Dis; 2021. pp. 897\u2013906.","DOI":"10.3233\/JAD-210549"},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0197-2456(98)00038-5","volume":"19","author":"SA Shumaker","year":"1998","unstructured":"Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, et al. The women\u2019s Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials Elsevier Inc. 1998;19:604\u201321.","journal-title":"Control Clin Trials Elsevier Inc"},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/gps.5130","volume":"34","author":"SA Gaussoin","year":"2019","unstructured":"Gaussoin SA, Espeland MA, Beavers DP, Casanova R, Garcia KR, Snively BM, et al. Dementia outcomes after addition of proxy-based assessments for deceased or proxy-dependent participants. Int J Geriatr Psychiatry Int J Geriatr Psychiatry. 2019;34:1403\u201311.","journal-title":"Int J Geriatr Psychiatry Int J Geriatr Psychiatry"},{"key":"772_CR24","doi-asserted-by":"crossref","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One PLoS One; 2014;9.","DOI":"10.1371\/journal.pone.0095192"},{"key":"772_CR25","doi-asserted-by":"crossref","unstructured":"Duggan MR, Butler L, Peng Z, Daya GN, Moghekar A, An Y et al. Plasma proteins related to inflammatory diet predict future cognitive impairment. Mol Psychiatry Mol Psychiatry; 2023.","DOI":"10.1038\/s41380-023-01975-7"},{"key":"772_CR26","doi-asserted-by":"crossref","unstructured":"Katz DH, Robbins JM, Deng S, Tahir UA, Bick AG, Pampana A et al. Proteomic profiling platforms head to head: leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci Adv Sci Adv; 2022;8.","DOI":"10.1126\/sciadv.abm5164"},{"key":"772_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-HH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nat Nat. 2023;622:329\u201338.","journal-title":"Nat Nat"},{"key":"772_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med Am Coll Physicians. 2009;150:604\u201312.","journal-title":"Ann Intern Med Am Coll Physicians"},{"key":"772_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10654-019-00499-1","volume":"34","author":"T Wilkinson","year":"2019","unstructured":"Wilkinson T, Schnier C, Bush K, Rannikm\u00e4e K, Henshall DE, Lerpiniere C, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol Eur J Epidemiol. 2019;34:557\u201365.","journal-title":"Eur J Epidemiol Eur J Epidemiol"},{"key":"772_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random Forest. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"772_CR31","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV, et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci Nat Neurosci. 2021;24:1302\u201312.","journal-title":"Nat Neurosci Nat Neurosci"},{"key":"772_CR32","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/hmg\/ddx062","volume":"26","author":"CN Spracklen","year":"2017","unstructured":"Spracklen CN, Chen P, Kim YJ, Wang X, Cai H, Li S, et al. Association analyses of east Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels. Hum Mol Genet Hum Mol Genet. 2017;26:1770\u201384.","journal-title":"Hum Mol Genet Hum Mol Genet"},{"key":"772_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41588-018-0064-5","volume":"50","author":"TJ Hoffmann","year":"2018","unstructured":"Hoffmann TJ, Theusch E, Haldar T, Ranatunga DK, Jorgenson E, Medina MW, et al. A large electronic-health-record-based genome-wide study of serum lipids. Nat Genet Nat Genet. 2018;50:401\u201313.","journal-title":"Nat Genet Nat Genet"},{"key":"772_CR34","first-page":"1220","volume":"143","author":"F de Wolf","year":"2020","unstructured":"de Wolf F, Ghanbari M, Licher S, McRae-McKee K, Gras L, Weverling GJ, et al. Plasma tau, neurofilament light chain and amyloid-b levels and risk of dementia; a population-based cohort study. Brain Brain. 2020;143:1220\u201332.","journal-title":"Brain Brain"},{"key":"772_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K, Weiner MW, Aisen P, et al. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol JAMA Neurol. 2017;74:557\u201366.","journal-title":"JAMA Neurol JAMA Neurol"},{"key":"772_CR36","doi-asserted-by":"crossref","unstructured":"Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu Rev Med Annu Rev Med; 1996. pp. 387\u2013400.","DOI":"10.1146\/annurev.med.47.1.387"},{"key":"772_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2020.06.001","volume":"95","author":"SC Burnham","year":"2020","unstructured":"Burnham SC, Laws SM, Budgeon CA, Dor\u00e9 V, Porter T, Bourgeat P, et al. Impact of APOE-\u03b54 carriage on the onset and rates of neocortical A\u03b2-amyloid deposition. Neurobiol Aging Neurobiol Aging. 2020;95:46\u201355.","journal-title":"Neurobiol Aging Neurobiol Aging"},{"key":"772_CR38","first-page":"4065","volume":"145","author":"TJ Betthauser","year":"2022","unstructured":"Betthauser TJ, Bilgel M, Koscik RL, Jedynak BM, An Y, Kellett KA, et al. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain Brain. 2022;145:4065\u201379.","journal-title":"Brain Brain"},{"key":"772_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-181282","volume":"69","author":"JB Toledo","year":"2019","unstructured":"Toledo JB, Habes M, Sotiras A, Bjerke M, Fan Y, Weiner MW, et al. APOE effect on Amyloid-\u03b2 PET spatial distribution, deposition rate, and Cut-Points. J Alzheimer\u2019s Dis. J Alzheimers Dis. 2019;69:783\u201393.","journal-title":"J Alzheimers Dis"},{"key":"772_CR40","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid \u03b2-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A Proc Natl Acad Sci U S A. 1993;90:9649\u201353.","journal-title":"Proc Natl Acad Sci U S A Proc Natl Acad Sci U S A"},{"key":"772_CR41","doi-asserted-by":"crossref","unstructured":"Olichney JM, Hansen LA, Lee JH, Hofstetter CR, Katzman R, Thal LJ. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer\u2019s disease. Ann N Y Acad Sci Ann N Y Acad Sci; 2000. pp. 138\u201343.","DOI":"10.1111\/j.1749-6632.2000.tb06360.x"},{"key":"772_CR42","doi-asserted-by":"crossref","unstructured":"Pase MP, Himali JJ, Bis JC, Beiser AS, Satizabal CL, Aparicio HJ, et al. Plasma YKL40 as a biomarker for brain aging and injury in three community cohorts. Volume 16. Alzheimer\u2019s Dement. John Wiley & Sons, Ltd; 2020. p. e042094.","DOI":"10.1002\/alz.042094"},{"key":"772_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.51730","volume":"10","author":"KA Walker","year":"2023","unstructured":"Walker KA, Duggan MR, Gong Z, Dark HE, Laporte JP, Faulkner ME, et al. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging. Ann Clin Transl Neurol. Ann Clin Transl Neurol. 2023;10:397\u2013407.","journal-title":"Ann Clin Transl Neurol"},{"key":"772_CR44","doi-asserted-by":"crossref","unstructured":"Walker KA, Chen J, Shi L, Yang Y, Fornage M, Zhou L et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci Transl Med Sci Transl Med; 2023;15.","DOI":"10.1126\/scitranslmed.adf5681"},{"key":"772_CR45","doi-asserted-by":"crossref","unstructured":"Kersten S. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism. J Lipid Res J Lipid Res; 2021.","DOI":"10.1016\/j.jlr.2021.100150"},{"key":"772_CR46","first-page":"49","volume":"347","author":"A Swanson","year":"2018","unstructured":"Swanson A, Wolf T, Sitzmann A, Willette AA. Neuroinflammation in Alzheimer\u2019s disease: pleiotropic roles for cytokines and neuronal pentraxins. Behav Brain Res Behav Brain Res. 2018;347:49\u201356.","journal-title":"Behav Brain Res Behav Brain Res"},{"key":"772_CR47","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.vph.2006.08.011","volume":"45","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, de la Martinez Y, et al. The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol Vascul Pharmacol. 2006;45:326\u201330.","journal-title":"Vascul Pharmacol Vascul Pharmacol"},{"key":"772_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2010.07.001","volume":"229","author":"H Jeon","year":"2010","unstructured":"Jeon H, Lee S, Lee WH, Suk K. Analysis of glial secretome: the long pentraxin PTX3 modulates phagocytic activity of microglia. J Neuroimmunol J Neuroimmunol. 2010;229:63\u201372.","journal-title":"J Neuroimmunol J Neuroimmunol"},{"key":"772_CR49","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/gerona\/glz217","volume":"75","author":"LM Miller","year":"2020","unstructured":"Miller LM, Jenny NS, Rawlings AM, Arnold AM, Fitzpatrick AL, Lopez OL, et al. Sex differences in the association between pentraxin 3 and cognitive decline: the cardiovascular health study. Journals gerontol - ser A Biol Sci Med Sci. J Gerontol Biol Sci Med Sci. 2020;75:1523\u20139.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"772_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nat Nat. 2020;577:399\u2013404.","journal-title":"Nat Nat"},{"key":"772_CR51","first-page":"502","volume":"205","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Fung ITH, Sankar P, Chen X, Robison LS, Ye L, et al. Depletion of NK cells improves cognitive function in the Alzheimer Disease Mouse Model. J Immunol J Immunol. 2020;205:502\u201310.","journal-title":"J Immunol J Immunol"},{"key":"772_CR52","doi-asserted-by":"crossref","unstructured":"Solana C, Tarazona R, Solana R. Immunosenescence of natural killer cells, inflammation, and Alzheimer\u2019s disease. Int. J. Alzheimers. Dis. Int J Alzheimers Dis; 2018.","DOI":"10.1155\/2018\/3128758"},{"key":"772_CR53","first-page":"1375","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, Allu\u00e9 JA, Sarasa L, Eichenlaub U, et al. Head-to-Head comparison of 8 plasma Amyloid-\u03b2 42\/40 assays in Alzheimer Disease. JAMA Neurol Am Med Association. 2021;78:1375\u201382.","journal-title":"JAMA Neurol Am Med Association"},{"key":"772_CR54","doi-asserted-by":"crossref","unstructured":"Deters KD, Napolioni V, Sperling RA, Greicius MD, Mayeux R, Hohman T et al. Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer\u2019s Disease (A4) Study. Neurology. Neurology; 2021;96:e1491\u2013500.","DOI":"10.1212\/WNL.0000000000011599"},{"key":"772_CR55","doi-asserted-by":"crossref","unstructured":"Masurkar AV, Marsh K, Morgan B, Leitner D, Wisniewski T. Factors Affecting Resilience and Prevention of Alzheimer\u2019s Disease and Related Dementias. Ann Neurol. Ann Neurol; 2024.","DOI":"10.1002\/ana.27055"},{"key":"772_CR56","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1002\/alz.13027","volume":"19","author":"PB Adkins-Jackson","year":"2023","unstructured":"Adkins-Jackson PB, George KM, Besser LM, Hyun J, Lamar M, Hill-Jarrett TG, et al. The structural and social determinants of Alzheimer\u2019s disease related dementias. Alzheimers Dement Alzheimers Dement. 2023;19:3171\u201385.","journal-title":"Alzheimers Dement Alzheimers Dement"},{"key":"772_CR57","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013. pp. 580\u20135."},{"key":"772_CR58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nat Nat. 2021;595:565\u201371.","journal-title":"Nat Nat"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-024-00772-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:03:35Z","timestamp":1730365415000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-024-00772-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s13024-024-00772-2","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants. The study design, data collection and analyses in this study were approved by the institutional review boards of WHIMS participating centers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the contents of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}